Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.

Iorgulescu, J Bryan; Sun, Chuxuan; Neff, Corey; Cioffi, Gino; Gutierrez, Catherine; Kruchko, Carol; Ruhl, Jennifer; Waite, Kristin; Negoita, Serban; Hofferkamp, Jim; Tihan, Tarik; McLendon, Roger; Brat, Daniel J; Ostrom, Quinn T; Barnholtz-Sloan, Jill S.

Iorgulescu JB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School.
Sun C; Department of Medical Oncology, Dana-Farber Cancer Institute.
Neff C; Department of Biostatistics, Duke University School of Medicine.
Cioffi G; Central Brain Tumor Registry of the United States.
Gutierrez C; Department of Neurosurgery, Duke University School of Medicine.
Kruchko C; Central Brain Tumor Registry of the United States.
Ruhl J; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute.
Waite K; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School.
Negoita S; Department of Medical Oncology, Dana-Farber Cancer Institute.
Hofferkamp J; Central Brain Tumor Registry of the United States.
Tihan T; Surveillance, Epidemiology, and End Results program, National Cancer Institute.
McLendon R; Central Brain Tumor Registry of the United States.
Brat DJ; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute.
Ostrom QT; Surveillance, Epidemiology, and End Results program, National Cancer Institute.
Barnholtz-Sloan JS; North American Association of Central Cancer Registries.

Neuro Oncol ; 25(2): 424-429, 2023 Feb 14.

Article en En | MEDLINE | ID: mdl-36534983

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Screening_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Screening_studies Idioma: En Año: 2023 Tipo del documento: Article